NCT05424939

Brief Summary

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 21, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
Last Updated

June 21, 2022

Status Verified

June 1, 2022

Enrollment Period

2 years

First QC Date

May 11, 2022

Last Update Submit

June 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time-to-starting chemotherapy

    Surgical procedures will be compared in terms of days-to-first chemotherapy

    1 year

Secondary Outcomes (3)

  • Mortality

    3 months

  • Morbidity

    3 months

  • Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year

    1 year

Interventions

ColectomyPROCEDURE

Colon resection

Any type of colostomy or ileostomy with or without bowel resection

Any palliative surgery without bowel resection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults who underwent surgery with a clinical and radiological diagnosis of obstructive colon tumors at any stage will be included in the study.

You may qualify if:

  • Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
  • Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT

You may not qualify if:

  • Benign diseases
  • Emergency surgery due to bleeding, perforation and other non-obstructive situations
  • Recurrent colon tumors
  • Rectal cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Medipol University Bahcelievler Hospital

Istanbul, 34196, Turkey (Türkiye)

RECRUITING

Medipol Mega Hospital

Istanbul, 34214, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Colonic NeoplasmsEmergencies

Interventions

Colectomy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Procedures, ColorectalDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Osman Civil, MD

    Medipol University

    STUDY DIRECTOR

Central Study Contacts

Naciye Cigdem Arslan, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2022

First Posted

June 21, 2022

Study Start

June 1, 2022

Primary Completion

May 31, 2024

Study Completion

May 31, 2024

Last Updated

June 21, 2022

Record last verified: 2022-06

Locations